Ponoi II Management, LLC
- SEC CIK
- 0001746488
- Latest filing
- Nov 14, 2022
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 5
- 0 vs. Q1 2021
- Portfolio value
- $123.4M
- −$7.18M (−5.5%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNSTConstellation Pharmaceuticals Inc | COM | 1,574,229 | $53.2M | 43.1% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $25.6M | 20.8% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $21.7M | 17.6% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 686,274 | $18.2M | 14.8% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 145,401 | $4.62M | 3.7% | 00.0% | Unchanged | History |